Oxygène Médicinal Liquide Sol (Oxygen)

Oxygen, the active ingredient in Oxygène Médicinal Liquide Sol, is a medical gas presented as a liquid for respiratory support use. It provides supplemental oxygen to patients with compromised breathing, typically in hospital and emergency settings. GNH USA supplies Oxygène Médicinal Liquide Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Oxygène Médicinal Liquide Sol is used in respiratory care pathways where oxygen supplementation is required: - Hypoxia: Restores adequate tissue oxygenation in patients with low blood‑oxygen levels. - Chronic Obstructive Pulmonary Disease (COPD): Improves exercise tolerance and reduces dyspnoea during exacerbations. - Post‑operative recovery: Supports adequate oxygenation following surgery and anesthesia. - Acute respiratory distress syndrome (ARDS): Provides essential oxygen to maintain arterial saturation. - Carbon monoxide poisoning: Displaces carbon monoxide from hemoglobin, accelerating recovery.

Oxygen therapy is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nasal dryness or irritation: Discomfort in the nasal passages due to airflow. - Headache: Mild to moderate headache associated with high flow rates. - Cough: Reflex cough triggered by the gas flow. - Thirst: Sensation of dry mouth during prolonged use.

Serious or Rare Side Effects: - Oxygen toxicity: Pulmonary inflammation or seizures at very high concentrations. - Fire hazard: Increased risk of combustion in oxygen‑rich environments. - Barotrauma: Lung injury from excessive airway pressure during mechanical ventilation. - Retinopathy of prematurity: Vision impairment in preterm infants exposed to high oxygen levels.

When prescribing or handling Oxygène Médicinal Liquide Sol, consider the following safety measures: - Patient assessment: Evaluate oxygen saturation and underlying lung disease before initiation. - Flow rate titration: Adjust to the lowest concentration that maintains target SpO₂. - Monitoring: Continuously monitor respiratory status and arterial blood gases. - Fire safety: Keep away from open flames, sparks, and smoking materials. - Storage: Store below 25°C: keep in the original container, protect from direct sunlight and moisture.

Oxygen may interact with certain medications and clinical conditions. Awareness of these interactions helps maintain safety and efficacy.

Major Interactions (Avoid): - Nitric oxide therapy: Excessive vasodilation and hypotension. - Dinitrate medications: Enhanced risk of severe hypotension.

Moderate Interactions (Monitor Closely): - Sedatives and opioids: Additive respiratory depression. - Chemotherapy agents (e.g., bleomycin): Increased risk of pulmonary toxicity. - Anesthetic gases: Potential alteration of oxygen‑hemoglobin dynamics. - High‑altitude exposure: May mask hypoxia symptoms, requiring closer monitoring.